Kythera Biopharmaceuticals Inc (KYTH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KYTH Annual Balance Sheets →
The data below summarizes Kythera Biopharmaceuticals Inc's balance sheet position from Jun 30 2014 to Jun 30 2015, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2015)
(Mar 31 2015) (Dec 31 2014) (Sep 30 2014) (Jun 30 2014)
Assets
Cash & cash equivalent92.31
Available-for-sale Securities, Current MA92.54
Cash & Short-term Investments184.00
Inventories4.01
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.62
Total Current Assets192.48
Equipment/Property/Plant Net2.07
Other Assets, Noncurrent0.89
Total Assets195.45
Liabilities
Accounts Payable, Current AC5.59
Accrued Liabilities, Current17.14
Notes Payable, Current NO0.00
Other Liabilities, Current0.95
Total Current Liabilities23.68
Long-term debt24.65
Total Long-term Debt24.65
Other liabilities, Noncurrent0.63
Total Liabilities48.96
Stockholders' Equity
Additional Paid In Capital Common Stock520.42
Retained Earnings / Accumulated Deficit-373.80
Other Equity-0.13
Common Stockholder's Equity146.49
Total Stockholder's Equity146.49
Liabilities & Stockholder's Equity195.45
4 historic quarters locked

Sign in to unlock the full Kythera Biopharmaceuticals Inc balance sheet history.

About KYTH Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.